Combination Study of Pomalidomide, Marizomib, and Low-Dose Dexamethasone in Relapsed and Refractory Multiple Myeloma

Clinical Trial ID NCT02103335

PubWeight™ 7.25^‹?›

🔗 Visit the ClinicalTrials.gov page for NCT02103335

Top papers